Fund Holdings — Logos Global Management LP

Total Portfolio Value:
$950.18M
Total Bought:
$450.37M
Total Sold:
$449.13M
Net Transaction:
+$1.24M
Notable People:
Logos Global Management Gp Llc, Arsani Hany William, Graham Gordon Walmsley
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
IDEAYA Biosciences, Inc.(IDYA)1,800,0001,500,000-300,000$64.04M$65.82M6.93%+$1.78M
Immunocore Holdings plcADS(IMCR)400,000900,000+500,000$27.33M$58.50M6.16%+$31.17M
Immunovant, Inc.(IMVT)1,200,0001,775,000+575,000$50.56M$57.35M6.04%+$6.79M
Ocular Therapeutix, Inc.(OCUL)4,000,0005,811,436+1,811,436$17.84M$51.99M5.47%+$34.15M
Sarepta Therapeutics, Inc.(SRPT)0400,000+400,000$0$51.78M5.45%+$51.78M
Olema Pharmaceuticals, Inc.(OLMA)4,383,8754,383,8750$54.38M$49.63M5.22%-$4.75M
Dyne Therapeutics, Inc.(DYN)1,880,0001,730,000-150,000$25.00M$49.11M5.17%+$24.11M
Apellis Pharmaceuticals Inc
COM
950,000800,000-150,000$56.87M$47.02M4.95%-$9.84M
Rocket Pharmaceuticals, Inc.(RCKT)1,275,0001,300,000+25,000$38.21M$35.02M3.69%-$3.19M
Silence Therapeutics plcADS(SLN)400,0001,476,061+1,076,061$6.95M$31.09M3.27%+$24.14M
Structure Therapeutics IncADS1,070,058720,058-350,000$43.62M$30.86M3.25%-$12.75M
Geron Corporation(GERN)09,000,000+9,000,000$0$29.70M3.13%+$29.70M
Celldex Therapeutics, Inc.(CLDX)0650,000+650,000$0$27.28M2.87%+$27.28M
Enliven Therapeutics Inc307,0761,574,220+1,267,144$4.25M$26.41M2.78%+$22.16M
Vera Therapeutics, Inc.CL A(VERA)0575,000+575,000$0$24.79M2.61%+$24.79M
Annexon, Inc.(ANNX)4,950,0003,050,000-1,900,000$22.47M$21.87M2.30%-$604.5K
Adverum Biotechnologies Inc01,499,999+1,499,999$0$21.21M2.23%+$21.21M
Design Therapeutics, Inc.(DSGN)5,032,5015,032,5010$13.34M$20.28M2.13%+$6.94M
Akero Therapeutics Inc800,000800,0000$18.68M$20.21M2.13%+$1.53M
Astria Therapeutics Inc544,9601,244,960+700,000$4.19M$17.52M1.84%+$13.34M
Cybin D/B/A Helus Pharma(HELP)040,000,000+40,000,000$0$16.54M1.74%+$16.54M
Xencor, Inc.(XNCR)0650,000+650,000$0$14.38M1.51%+$14.38M
CG Oncology, Inc.(CGON)0300,000+300,000$0$13.17M1.39%+$13.17M
Engene Holdings Inc
COM
0800,000+800,000$0$12.88M1.36%+$12.88M
Kyverna Therapeutics, Inc.(KYTX)0500,000+500,000$0$12.42M1.31%+$12.42M
Viridian Therapeutics, Inc.(VRDN)600,000700,000+100,000$13.07M$12.26M1.29%-$811.0K
Cullinan Therapeutics, Inc.(CGEM)0700,000+700,000$0$11.93M1.26%+$11.93M
Immatics N.V.SHS(IMTX)01,000,000+1,000,000$0$10.51M1.11%+$10.51M
Spyre Therapeutics, Inc.(SYRE)150,000250,000+100,000$3.23M$9.48M1.00%+$6.25M
Lineage Cell Therapeutics, Inc.(LCTX)06,250,000+6,250,000$0$9.25M0.97%+$9.25M
Praxis Precision Medicines, Inc.(PRAX)0150,000+150,000$0$9.15M0.96%+$9.15M
Applied Therapeutics Inc1,660,0001,350,000-310,000$5.56M$8.98M0.94%+$3.42M
Syndax Pharmaceuticals, Inc.(SNDX)0350,000+350,000$0$8.33M0.88%+$8.33M
Trevi Therapeutics, Inc.(TRVI)02,200,000+2,200,000$0$7.59M0.80%+$7.59M
Cytokinetics, Incorporated(CYTK)1,625,000100,000-1,525,000$135.67M$7.01M0.74%-$128.66M
Kura Oncology, Inc.(KURA)0300,000+300,000$0$6.40M0.67%+$6.40M
Neumora Therapeutics, Inc.(NMRA)382,345382,3450$6.52M$6.19M0.65%-$325.9K
Atyr Pharma Inc5,850,0003,100,000-2,750,000$8.25M$6.04M0.64%-$2.20M
Janux Therapeutics, Inc.(JANX)0150,000+150,000$0$5.65M0.59%+$5.65M
Elevation Oncology Inc01,000,000+1,000,000$0$5.13M0.54%+$5.13M
Nextcure Inc01,925,000+1,925,000$0$4.29M0.45%+$4.29M
Allakos Inc2,900,0002,900,0000$7.92M$3.65M0.38%-$4.26M
Unicycive Therapeutics Inc03,469,927+3,469,927$0$3.01M0.32%+$3.01M
Boundless Bio, Inc.(BOLD)0200,000+200,000$0$2.85M0.30%+$2.85M
Tourmaline Bio Inc284,37299,208-185,164$7.44M$2.27M0.24%-$5.17M
COMPASS Pathways plcADS(CMPS)500,000257,980-242,020$4.38M$1.81M0.19%-$2.56M
Io Biotech Inc493,827493,8270$928.4K$854.3K0.09%-$74.1K
Immunic, Inc.(IMUX)421,184421,1840$631.8K$556.0K0.06%-$75.8K
Cypherpunk Technologies Inc.(CYPH)039,500+39,500$0$105.1K0.01%+$105.1K
Nuvation Bio Inc.W EXP 07 07 202(NUVB)66,66666,6660$4.0K$22.7K0.00%+$18.7K
Acelyrin Inc1,250,0000-1,250,000$9.32M$0—-$9.32M
Ambrx Biopharma Inc2,100,0000-2,100,000$29.90M$0—-$29.90M
Arcus Biosciences, Inc.(RCUS)325,0000-325,000$6.21M$0—-$6.21M
argenx SEADR(ARGX)145,0000-145,000$55.16M$0—-$55.16M
Avidity Biosciences Inc775,0000-775,000$7.01M$0—-$7.01M
Delcath Systems, Inc.(DCTH)300,0000-300,000$1.25M$0—-$1.25M
Edgewise Therapeutics, Inc.(EWTX)950,0000-950,000$10.39M$0—-$10.39M
Fulcrum Therapeutics, Inc.(FULC)1,200,0000-1,200,000$8.10M$0—-$8.10M
Icosavax Inc300,0000-300,000$4.73M$0—-$4.73M
Inhibrx Inc100,0000-100,000$3.80M$0—-$3.80M
Karuna Therapeutics Inc90,0000-90,000$28.49M$0—-$28.49M
Kiniksa Pharmaceuticals LtdCL A150,0000-150,000$2.63M$0—-$2.63M
MoonLake ImmunotherapeuticsCL A(MLTX)150,0000-150,000$9.06M$0—-$9.06M
Morphic Hldg Inc200,0000-200,000$5.78M$0—-$5.78M
Morphosys AgADS1,475,0000-1,475,000$14.60M$0—-$14.60M
Rayzebio Inc568,1730-568,173$35.32M$0—-$35.32M
Repare Therapeutics Inc600,0000-600,000$4.38M$0—-$4.38M
Revolution Medicines, Inc.(RVMD)350,0000-350,000$10.04M$0—-$10.04M
Ventyx Biosciences Inc2,000,0000-2,000,000$4.94M$0—-$4.94M
Xenon Pharmaceuticals Inc.(XENE)150,0000-150,000$6.91M$0—-$6.91M
Page 1 of 1
Logos Global Management LP — 13F Holdings — Q1 2024 | TickerTrail